GH Research (GHRS) Other Accumulated Expenses (2021 - 2025)

GH Research (GHRS) recorded quarterly Other Accumulated Expenses of $4.2 million in Q4 2025, down 31.65% quarter-over-quarter from $6.2 million in Q3 2025, and down 14.42% on a YoY basis from $5.0 million in Q4 2024.

GH Research (GHRS) Other Accumulated Expenses (2021 - 2025) Analysis & Trends

GH Research's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $4.2 million for Q4 2025.

  • In Q4 2025, Other Accumulated Expenses fell 14.42% year-over-year to $4.2 million; the TTM figure through Dec 2025 stood at $4.2 million (down 14.42% YoY), while the FY2025 annual figure was $4.2 million, down 14.42% from the prior year.
  • Other Accumulated Expenses was $4.2 million for Q4 2025 at GH Research, down from $6.2 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $6.6 million in Q3 2024 to a low of $819000.0 in Q3 2021.
  • Historically, Other Accumulated Expenses has averaged $3.7 million across 5 years, with a median of $3.4 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses soared 143.37% in 2023, then decreased 14.42% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $3.0 million in 2021, then fell by 10.22% to $2.7 million in 2022, then advanced by 7.09% to $2.9 million in 2023, then jumped by 72.84% to $5.0 million in 2024, then declined by 14.42% to $4.2 million in 2025.
  • The last three Other Accumulated Expenses figures came in at $4.2 million (Q4 2025), $6.2 million (Q3 2025), and $6.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 GH Research 9.73 Bn 9.63 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.24 Mn
Sep 30, 2025 6.21 Mn
Jun 30, 2025 6.16 Mn
Mar 31, 2025 4.81 Mn
Dec 31, 2024 4.96 Mn
Sep 30, 2024 6.57 Mn
Jun 30, 2024 4.97 Mn
Mar 31, 2024 3.39 Mn
Dec 31, 2023 2.87 Mn
Sep 30, 2023 3.17 Mn
Jun 30, 2023 3.38 Mn
Mar 31, 2023 3.38 Mn
Dec 31, 2022 2.68 Mn
Sep 30, 2022 1.64 Mn
Jun 30, 2022 1.39 Mn
Mar 31, 2022 2.52 Mn
Dec 31, 2021 2.98 Mn
Sep 30, 2021 819,000.00